Latest Fresenius Stories
The Firm is representing individuals in GranuFlo lawsuits who suffered heart attacks, strokes, sudden cardiac death, and other serious heart events, allegedly due to the use of GranuFlo and NaturaLyte.
The Firm is evaluating GranuFlo lawsuits on behalf of individuals who allegedly suffered catastrophic heart problems associated with the GranuFlo recall for GranuFlo and NaturaLyte dialysis concentrates.
An increasing number of American patients are driving demand for dialysis devices and concentrates; a market value expected to reach $2 billion. Vancouver, BC
The Firm is investigating dialysis lawsuits on behalf of individuals who allegedly suffered serious and life-threatening heart problems associated with last year’s recall of Fresenius Medical
More than 229 GranuFlo lawsuits allegedly stemming from an FDA Class I recall contend GranuFlo and NaturaLyte dialysis drugs caused patients to experience life-threatening heart side effects,
Reportbuyer.com just published a new market research report:
Lawsuits Consolidated in Multidistrict Litigation, Will Help Efficiency of Cases LOS ANGELES (PRWEB) August 20, 2013 Burton LeBlanc, shareholder at the
Lawyers for dialysis patients alleging that NaturaLyte and GranuFlo products caused life-threatening heart irregularities and Fresenius attorneys will update progress of litigation.